The present study was undertaken to assess the role of ovarian renin-angiotensin system (RAS) in the preovulatory cascade induced by gonadotropin exposure. In the in vitro perfused rabbit ovaries, exposure to human chorionic gonadotropin (hCG) enhanced the secretion rate of angiotensin II (Ang II) within 1 h. The secretion rate reached maximal levels at 6 h and then declined thereafter. The intrafollicular Ang II content and renin-like activity were also significantly increased at 2 and 4 h after exposure to hCG, compared with control ovaries perfused with medium alone. The level of intrafollicular Ang II after hCG exposure significantly exceeded the concentration of Ang II in an equivalent volume of plasma. The addition of 1 ,uM captopril to the perfusate significantly inhibited the secretion rate of Ang II stimulated by hCG; however, captopril affected neither the ovulatory efficiency nor prostaglandin production in ovaries treated with hCG. Captopril significantly inhibited the resumption of meiosis in the ovulated ova and follicular oocytes stimulated by hCG. The administration of 100 ,ug Ang II at 2-h intervals to the perfusate reversed the inhibitory effects of captopril on hCG-induced oocyte maturation. In conclusion, these data indicate that gonadotropin stimulates renin-like activity and Ang11 production in the rabbit ovary. Ovarian renin-angiotensin system may play an important role in the process of oocyte maturation after exposure to gonadotropin. (J.
Introduction
A functional local renin-angiotensin system (RAS)' is known to exist in the ovary (1) (2) (3) (4) (5) (6) . Pellicer et al. (7) demonstrated that the intraperitoneal administration ofan angiotensin II (Ang II) receptor antagonist, saralasin, blocked ovulation in immature rats that were treated with pregnant mare's serum gonadotropin and human chorionic gonadotropin (hCG). Our previous 1. Abbreviations used in this paper: ACE, angiotensin I-converting enzyme; Ang II, angiotensin II; GVBD, germinal vesicle breakdown; hCG, human chorionic gonadotropin; RAS, renin-angiotensin system. study revealed that the addition ofAng II in the perfusate at 2-h intervals induced oocyte maturation and ovulation in the in vitro perfused rabbit ovaries in the absence of gonadotropin, and that the concomitant addition of saralasin completely blocked Ang 11-induced ovulation (8) . These results indicate that Ang II has a direct role in follicle rupture and oocyte maturation, and they support the hypothesis that Ang II produced in the ovary may act locally in the process ofovulation. An intrinsic RAS in the rabbit ovary may be an intermediary in the gonadotropin-induced ovulation. However, Husain et al. (3) did not find the expected autoradiographic distribution of Ang II receptors in every developing rat follicle, suggesting that not all preovulatory follicles necessarily respond to exogenous or endogenous Ang II. This discrepancy in the effects ofAng II on gonadotropin-induced ovulation impedes a better understanding of the physiological role of Ang II in ovulation.
The finding of higher follicular concentrations ofprorenin, renin, and angiotensinogen in humans, and the identification of angiotensinogen and renin messenger RNA in the rat ovary, suggest the presence ofa local RAS in the ovary ( 1, 2, 5, 9, 10). The evidence that the ovary secretes prorenin into the follicular fluid and plasma at the time of gonadotropin surge of the normal menstrual cycle ( I 1, 12) and after hCG administration to ovarian-stimulated patients ( 13) further substantiates the hypothesis that the ovarian RAS may play an important role in the function of ovarian follicle. We found that the rates ofAng II secretion were enhanced by gonadotropin in perfused rabbit ovaries, and that the concomitant addition of saralasin inhibited hCG-induced ovulation in a dose-dependent manner (8) . Kuo et al. also have demonstrated that Ang II has a direct effect on the rabbit ovary, stimulating both ovulation and oocyte maturation in the absence of gonadotropin ( 14) . These observations point toward a potentially important role of ovarian RAS in the preovulatory cascade induced by gonadotropin exposure, and prompted us to investigate changes in the intrafollicular renin activity and the ovarian secretion rate ofAng II in the process ofovulation. Since local Ang II may be a significant autocrine or paracrine modulator of ovarian function (7, 8, 14) , we also studied the effects of captopril, an angiotensin I-converting enzyme (ACE) inhibitor, on hCG-induced ovulation and oocyte maturation.
Methods
Animals. Sexually mature female Japanese white rabbits weighing 3.5-4.5 kg, which were cared for according to the guideline of Kyorin University School of Medicine, were isolated for a minimum of 3 wk. The rabbits were caged individually and fed water and a diet of Purina rabbit chow (Clea Japan Inc., Tokyo, Japan) ad libitum under conditions of controlled light and temperature. They were anesthetized with intravenous sodium pentobarbital (32 mg/kg), administered heparin sulfate ( 120 U/kg) for anticoagulation, and then subjected to laparotomy. Ovaries were excluded from further study ifthey appeared immature, or if 2 50% of the surface follicles were hemorrhagic.
Ovarian perfusion. Although the details of the standard perfusion system have been modified over the years, the basic components have remained constant ( 15 ) . The ovarian artery and vein were cannulated in situ after ligation of the major anastomotic connections as previously described ( 16, 17) . The ovary was removed along with its artery, vein, and supporting adipose tissue, and immediately placed in a perfusion chamber. The perfusion fluid consisted of 150 ml of medium 199 (Gibco Laboratories, Grand Island, NY) containing 1% BSA (Fraction V powder; Sigma Chemical Co., St. Louis, MO), which was supplemented with heparin sulfate, insulin, streptomycin, and penicillin G, and adjusted to a pH of 7.4. BSA was added to the basic perfusion fluid to increase the oncotic pressure and reduce edema formation ( 16) . Ovaries were observed every 15 min for evidence offollicle growth and rupture throughout the 12 h of perfusion.
At the time offollicle rupture, the ovulated ovum surrounded by its cumulus mass was recovered carefully from the ovarian surface with a Pasteur pipette. The time interval between hCG or Ang II administration and follicle rupture was recorded. The ovulatory efficiency (percent offollicles > 1.5 mm that ovulated) was calculated for each group. At the end ofthe perfusion, follicular oocytes were recovered by aspiration from mature follicles > 1.5 mm in diameter. Both the ovulated ova and follicular oocytes were assessed for stage of maturity and signs of degeneration, as previously described ( 18) . Oocytes were placed on slides, fixed in 2.5% glutaraldehyde, and then stained with 0.25% lacmoid in 45% acetic acid for microscopic evaluation. The degree of ovum maturity was expressed as the percentage of ova that achieved germinal vesicle breakdown (GVBD). Ova were also assessed for degenerative changes including vacuolation, cytolysis, necrosis, fragmentation, and loss of spherical shape.
Experimental design. The first experiment using 72 rabbits was undertaken to determine whether the addition of hCG to the perfusate would stimulate the production of Ang II and renin activity in the perfused rabbit ovaries. Both ovaries were perfused with medium alone. 30 min after the onset of perfusion, 50 IU of hCG (CH-446, biological activity = 3,830 IU/mg; Organon, Oss, the Netherlands) was added to the perfusate ofone ovary. Ovaries were perfused for 12 h after hCG administration. Both arterial and venous samples were obtained in six perfused rabbit ovaries before the administration of hCG and 1, 2, 4, 6, 8, and 12 h thereafter to determine the ovarian secretion rate ofAng II. The perfusate was introduced through the ovarian artery cannula, and was collected from the cannulated ovarian vein and recycled. The ovarian secretion rate of Ang II was calculated by determining the difference in concentrations between the venous and arterial samples as described previously ( 17) . Samples were stored at -80°C until the concentrations ofAng II were determined. The first ovulation in this system using ovarian artery and vein cannulation occurred after 8 h of exposure to hCG (8, 17, 19) . The mean time interval from ovulatory stimulus to ovulation has been shown to be 9.51±0.57 h after exposure to hCG ( 17) . Therefore, in the experiment for determining the intrafollicular content of Ang II and renin-like activity, ovarian perfusion was terminated before hCG administration and 1, 2, 4, 6, and 8 h after the exposure to hCG. Six ovaries from six different rabbits were examined at each interval. Mature follicles perfused with or without hCG were immediately excised at each time point ofperfusion and stored at -80°C until the intrafollicular Ang II content and renin-like activity were determined. In additional experiments, 30 
Results
The ovarian secretion rate of Ang II in the in vitro perfused rabbit ovaries, which was calculated by determining the difference in concentrations between the venous and arterial samples, was undetectable in the unstimulated control ovaries during the entire perfusion period (Fig. 1) . Exposure to hCG enhanced the secretion ofAng II in perfused rabbit ovaries within 1 h. The maximal secretion of Ang 11 (74±12 pg/min per ovary) occurred at 6 h and declined thereafter. The intrafollicular renin activity was 3.96±0.58 ng/mg per h in unstimu- Ovarian secretion rate (pg/ min per ovary) was calculated by determining the difference in concentrations between venous and arterial samples. Data points regarding hCG-treated ovaries represent the mean±SEM of at least six perfused rabbit ovaries. Values with asterisks differed significantly from values in ovaries perfused with hCG alone; *P < 0.05; **P < 0.01. lated ovaries and did not change substantially during the 12 h of perfusion. In hCG-treated ovaries, the intrafollicular reninlike activity began to increase within 1 h after exposure to hCG (Fig. 2) . By 4 h after hCG administration, the intrafollicular renin-like activity increased approximately twofold (P < 0.01 ) to 8.27±0.42 ng/mg per h and returned to pretreatment levels in 8 h. Similar to the alteration of intrafollicular renin-like activity, the intrafollicular content of Ang II significantly increased 2 h after exposure to hCG, reached a maximum of 4 h, and thereafter declined (Fig. 3) . The intrafollicular renin activity and Ang II content were significantly increased at 2 and 4 h after exposure to hCG, compared with values in control ovaries perfused with medium alone. The level ofAng II in the mature follicle exceeded its concentration in the plasma by 10-to 60-fold (Fig. 4) . The peripheral Ang II concentration did not change substantially during the process of ovulation after gonadotropin exposure, unlike the intrafollicular content of Ang II. Ovulation occurred in all ovaries treated with hCG alone or with hCG plus captopril at a concentration of 1 ,tM, while any ovaries perfused with medium alone or captopril failed to ovulate in the absence ofgonadotropin (Table I ). The mean number of ovulations per ovary and ovulatory efficiency were reduced in the ovaries that were perfused with captopril, as compared with the hCG-treated control; however, these differences were not significant. Additionally, the time of ovulation in the captopril-treated and control ovaries did not differ significantly.
The addition of captopril to the perfusate significantly inhibited the secretion rate of Ang II in ovaries stimulated by hCG during the entire period of perfusion (Fig. 1) . Furthermore, the intrafollicular Ang II content was significantly reduced in captopril-treated ovaries beginning at 2 h after exposure to hCG (Fig. 3) . The concentrations ofintrafollicular Ang II in ovaries perfused with hCG plus captopril did not differ significantly from control ovaries perfused with medium alone. Although the addition of captopril to the perfusate increased the intrafollicular renin-like activity in the hCG-treated ovaries, the difference was not significant (Fig. 2) . The secretion rates of PGE2 and PGF2a in ovaries perfused with medium alone were very low throughout the entire period of perfusion (Fig. 5) . Adding hCG to the perfusate significantly increased the production of PGE2 and PGF2. at The majority of ovulated ova and follicular oocytes resumed meiotic maturation in response to hCG exposure during perfusion (Fig. 6) . The concomitant addition of captopril in a concentration of 1 AM significantly inhibited the resumption of meiosis in the ovulated ova and follicular oocytes in ovaries perfused with hCG. However, examination of the ovulated ova and follicular oocytes for evidence of degeneration revealed no significant differences between two groups. The treated with hCG alone. *P < 0.001; **P administration of 100 ,ug ofAng II at 2 ate significantly stimulated the meioti lated ova and follicular oocytes in the (Table II) RAS in the ovulatory process. These data, together with other information showing that the increase in human plasma prorenin concentration occurs almost exactly at the time of ovula-Z-h intervals to the perfustion ( 1, 11 ), and that gonadotropin stimulates renin activity ic maturation of the ovuand Ang II immunoreactivity in follicular fluid (5), support absence of gonadotropin the existence in the ovary ofan intrinsic RAS, which is responsirsed the inhibitory effects ble as an intermediary of gonadotropin-induced ovulation. maturation.
However, the elevation in the intrafollicular renin-like activity and Ang II in the in vitro perfused rabbit ovaries does not mean that either active renin or Ang II is normally present in these concentrations in vivo, since inadvertent activation of prorenin can occur in vitro (29) . Therefore, one cannot exclude the icated in the paracrlne or possibility that the intrafollicular serine proteases, which are ction.luTheg loca systems produced by follicular cells after gonadotropin surge ( 19, 30, 31 ) , may stimulate the generation ofAng II in the preovulatory follicles by activation of prorenin to renin and/or by the direct cleavage of angiotensinogen. ition in hCG-treated Autoradiographic studies (3, 32, 33) revealed a lack of Ang a Captopril II receptors in preovulatory follicles containing the luteinizing h Ang II hormone receptor, suggesting that not all preovulatory follicles respond necessarily to exogenous or endogenous Ang II. In a es previous study from our laboratory, 1 00 gg of Ang II at 2-h intervals induced ovulation in all ovaries in the absence of goopril nadotropin, but ovulatory efficiency was significantly lower g II Ang II Medium than in the hCG-treated ovaries (8) . Furthermore, the addition /2 h) (100 g/2 h) alone of saralasin, a specific receptor antagonist of Ang II, to the perfusate blocked the hCG-induced ovulation in the perfused 6 6 rabbit ovaries in a dose-dependent manner (8) . However, saralasin did not completely block hCG-induced ovulation. This 6 0 implies that other components within the preovulatory follicular environment than ovarian RAS may also be required for 4.0 42.5±5.8 follicles to rupture. Alternatively, the failure of Ang II to induce ovulation with an efficiency comparable to that ofhCG implies 3.0 § 48.6±5. 5 that the response of preovulatory follicles to Ang II leading to 10.511 44.2±7.7 5.7±2. 6 ovulation can be attributed to the functional heterogeneity of follicles within the ovary. The present study demonstrated that .eded to rupture during pergonadotropin stimulated the renin activity and Ang II content Id follicular oocytes that in the preovulatory follicles and the production of Ang II by the .05 when compared with perfused rabbit ovaries. In addition to the presence in the ovary of all components of RAS, the ovary has been shown to contain angiotensinogen and renin messenger RNA (9, 10) . These results indicate that all reactions leading to Ang II formation can potentially occur in ovarian cells resulting in follicle rupture. Several classes of potent and specific nonpeptide inhibitors have been synthesized in an effort to produce active ACE inhibitors that could be useful as antihypertensive agents (34) . Captopril is thought to bind the active site of ACE in a manner analogous to endogenous substrates, and has been widely used in experiments designed to define the biological function of ACE (35) (36) (37) (38) . The addition of captopril to the perfusate did not inhibit hCG-induced ovulation, despite significant reductions in both the intrafollicular Ang II content and the secretion rate ofAng II in ovaries perfused with hCG. These findings are in accordance with data showing that short and long term infusions ofcaptopril in immature rats, in which ovulation was induced by sequential treatment with pregnant mare's serum gonadotropin and hCG, did not significantly affect ovulation compared with that in vehicle-infused control rats (37) . Our previous study demonstrated that saralasin, an Ang II receptor antagonist, significantly inhibited hCG-induced ovulation in the experiment using the same procedure and animals (8) . Although this discrepancy between the results with captopril and saralasin remains to be explained, the use of ACE inhibitors as reagents to assess the function of RAS has been criticized on the basis that at least some of these compounds have additional effects, including the prevention ofthe hydrolysis of bradykinin (34) . One possibility is that a decrease in the levels of ACE in the preovulatory follicles by captopril administration may allow a rise in intrafollicular levels of bradykinin, since ACE degrades bradykinin (34, 39) . Bradykinin, a physiological substrate for ACE, has been shown to be obligatory for ovulation in the perfused rabbit ovary (40) . The present findings showing a lack of antiovulatory response ofcaptopril may depend on the relative increased levels of bradykinin in the preovulatory follicles. Daud et al. demonstrated that rat follicles containing high levels of ACE on their granulosa cells are exclusively developing or atretic (37) . Another possibility is that ACE inhibition by captopril apparently does not modify the normal ovulatory process induced by gonadotropin exposure, since ACE levels are markedly reduced in preovulatory follicles (37) . Clearly, additional experiments with selective antagonists ofACE are needed to assess the role ofintraovarian Ang II in the process of ovulation.
Growing evidence suggests that PGs may be involved in the process of ovulation via local actions at the level of the ovary (41) (42) (43) (44) . We recently found that the inhibition of Ang IIstimulated PG production by indomethacin led to the complete blockade of Ang II-induced ovulation (unpublished observations). Furthermore, exposure to saralasin inhibited hCG-stimulated PG production in a dose-dependent manner, concomitant with the blockade of ovulation. This implies that Ang II induces ovulation in the rabbit ovary, at least in part, by a mechanism that depends on a stimulatory effect of Ang II on PG production. In the present study, captopril significantly inhibited both the hCG-stimulated secretion rate ofAng II and intrafollicular content ofAng II, but did not reduce PG production by perfused rabbit ovaries. The ovarian biosynthesis ofPG did not differ significantly between hCG-and hCG plus captopril-treated ovaries despite a significant inhibition of Ang II production in the ovaries treated with captopril. These observations argue against the hypothesis that Ang II plays an intermediary role in the preovulatory cascade induced by gonadotropin exposure.
It has been reported that the treatment ofcultured endometrial decidual cells with enalaprilat, an another ACE inhibitor, inhibits the production of PGE2 in a dose-dependent manner, but that the concurrent administration of Ang II does not reverse the inhibitory effect of enalaprilat (38) (45) (46) (47) . Our previous study also revealed that bradykinin significantly stimulated the production of PG by perfused rabbit ovaries (40) . The relatively high levels of bradykinin in the ovaries treated with the ACE inhibitor may compensate for the reduction in PG production by ovaries in reduced levels of Ang II, and thus did not block the normal ovulatory response. Further study is needed to assess the relative contributions ofbradykinin and of the blockade of Ang II production to the effects of ACE inhibitors on the ovarian RAS.
In the previous study from our laboratory, Ang II stimulated significantly the meiotic maturation of ovulated ova and follicular oocytes in the absence of gonadotropin stimulus (8) .
Furthermore, the concomitant addition of saralasin at 2 X 10-6 M inhibited significantly hCG-induced oocyte maturation. In contrast, Kuo et al. ( 14) demonstrated using the same rabbit ovary perfusion system that Ang II did not play a critical role in the meiotic maturation. The discrepancies between our findings and other study may be caused by the differences in the doses of saralasin used and in the administration method of Ang II. Indeed, the inhibitory effect of saralasin on hCG induced oocyte maturation was less effective than that of captopril. The present study demonstrated that the inhibition of endogenous ACE by captopril significantly blocked the meiotic maturation of ovulated ova and follicular oocyte stimulated by exposure to hCG. Thus, as has been described for the role of Ang II in the ovulatory process (7, 8, 14) , locally produced Ang II in the ovary may be a centerpiece of an intraovarian regulatory loop leading to the promotion of key preovulatory events. Furthermore, the addition of Ang II to the perfusate reversed the inhibitory effects of captopril on the hCG-induced oocyte maturation, ruling out the possibility that the inhibitory effect of captopril is not caused by a nonspecific action. These data imply that the generation of Ang II by ACE within the preovulatory follicles plays an important intermediary role after exposure to the gonadotropin surge. Ang II has been also shown to promote progesterone-induced maturation in oocytes from Xenopus laevis by mobilizing Ca2+ via a signal transferred through the gap junctions between the follicular cells and the oocyte (48) . Recent data derived from the in vitro fertilization program in humans demonstrate that the prorenin concentration in the follicular fluid is correlated with follicular development, oocyte-cumulus complex maturity, and oocyte viability, resulting in successful pregnancy (49, 50) . These observations, in conjunction with data showing the immunolocalization of angiotensin converting enzyme in the rabbit oolemma (51 ), suggest that the ovarian RAS may be involved in the process of maturation of mammalian oocyte as well. The clinical use of ACE inhibitors in hypertensive women who seek to become pregnant may inhibit oocyte maturation in the normal ovulatory process, suggesting that these analogues would be contraindicated in such cases.
In conclusion, Ang II was synthesized and secreted by mature ovarian follicles of the rabbit in response to gonadotropin exposure. The addition of captopril to the perfusate significantly inhibited hCG-induced oocyte maturation, but not ovulation. These results suggest that the ovarian RAS may play an important role in the process ofoocyte maturation after gonadotropin exposure. Further studies to elucidate the function of the ovarian RAS may have relevance to many aspects ofreproductive physiology in mammals.
